Physician profile
Vanessa Treps
NPI 1043440316
$1,565.95
in general payments reported to CMS, 2019-2025
13 companies · $473 in 2025
The $473 reported for 2025 was more than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $73.01 · 2022: $113 · 2023: $615 · 2024: $291 · 2025: $473.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,185 · Education: $194.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,185.26 |
| Education | $194.30 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mayne Pharma Commercial LLC | $624.52 | 2023-2025 | Bijuva, Annovera |
| Astellas Pharma US INC | $505.06 | 2023-2025 | Veozah |
| Abbvie INC. | $109.15 | 2021-2023 | |
| Axonics, INC. | $94.64 | 2023 | Axonics, Bulkamid |
| Janssen Pharmaceuticals, INC | $63.76 | 2021-2022 | |
| Astrazeneca Pharmaceuticals LP | $30.66 | 2022 | |
| Exact Sciences Corporation | $25.58 | 2025 | Cologuard Collection Kit |
| Glaxosmithkline, LLC. | $24.83 | 2022 | |
| Hologic Sales and Service, LLC | $23.06 | 2025 | Sonata Sonography-Guided Transcervical Fibroid Ablation System |
| Idorsia Pharmaceuticals US INC | $20.98 | 2022 | |
| Exeltis, USA INC. | $16.66 | 2024 | Slynd |
| Meditrina | $13.70 | 2023 | |
| Millicent US INC | $13.35 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Vanessa Treps listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.